Shares of Azitra, Inc. (NYSEAMERICAN:AZTR – Get Free Report) traded down 2.5% during trading on Tuesday . The stock traded as low as $0.56 and last traded at $0.60. 231,676 shares traded hands during mid-day trading, a decline of 76% from the average session volume of 948,409 shares. The stock had previously closed at $0.61.
Azitra Trading Down 4.0 %
The company has a debt-to-equity ratio of 0.01, a current ratio of 0.77 and a quick ratio of 0.77.
Azitra (NYSEAMERICAN:AZTR – Get Free Report) last announced its quarterly earnings data on Monday, August 12th. The company reported ($2.74) earnings per share for the quarter, missing analysts’ consensus estimates of ($2.59) by ($0.15). The business had revenue of $0.01 million during the quarter. Equities research analysts expect that Azitra, Inc. will post -3.06 EPS for the current fiscal year.
About Azitra
Azitra, Inc, an early-stage biopharmaceutical company, develops therapies for precision dermatology using engineered proteins and live biotherapeutic products to treat skin diseases. It develops ATR-12, a genetically modified strain of S. epidermidis, which is in Phase Ib clinical trial for treating Netherton syndrome, a skin disease.
Featured Articles
- Five stocks we like better than Azitra
- What is the FTSE 100 index?
- Why Meta’s Pre-Earnings Dip Could Be A Golden Entry Opportunity
- What is a SEC Filing?
- Spirit Airlines Stock Nearly Doubled: Are Clear Skies Ahead?
- Trading Stocks: RSI and Why it’s Useful
- Tesla Stock: Buy the Dips, Sell the Rips
Receive News & Ratings for Azitra Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Azitra and related companies with MarketBeat.com's FREE daily email newsletter.
